Search the Newsreel

Instacart (Maplebear Inc.) Q2 2026 Earnings Call Summary

Instacart (Maplebear Inc.) Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. GTV …

Carter's, Inc. (CRI) stock price, news, quote and history

This article provides a comprehensive overview of Carter's, Inc. (CRI) stock, including its current price, historical performance, key financial statistics, and analyst insights. It details the company's business segments, product offerings, and market presence within the apparel retail sector, alongside comparative data with similar …

Quantinno Capital Management LP Buys 41,213 Shares of Maplebear Inc. $CART

Quantinno Capital Management LP increased its stake in Maplebear Inc. (NASDAQ:CART) by 27.7% in the first quarter, purchasing an additional 41,213 shares, bringing its total holdings to 190,090 shares valued at approximately $7.1 million. Other institutional investors like Royal Bank of Canada and Goldman …

Instacart's core business delivers double-digit GTV, revenue growth, EPS misses (CART:NASDAQ)

Instacart (CART) exceeded Wall Street's second-quarter expectations with strong performance in gross transaction value (GTV), average order value, and advertising revenue, leading to a 14% increase in total revenue to over $1 billion. Despite this growth, the company's EPS missed estimates.

Maplebear (CART) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Maplebear (CART) reported revenue of $1.04 billion, up 14.1% over the same period last year. EPS came in at $0.45, compared to $0.41 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.02 …

Instacart Q2 2026 Earnings: Revenue Rises 14% as Free Cash Flow Accelerates

Instacart (NASDAQ: CART) reported a 14% increase in Q2 2026 revenue, reaching $1.043 billion, with diluted EPS up to $0.45. While free cash flow more than doubled and adjusted EBITDA grew significantly, GAAP net income declined by 4% due to a narrowed gross margin …

Instacart (NASDAQ:CART) Exceeds Q2 CY2026 Expectations, Stock Soars

Instacart (NASDAQ:CART) Exceeds Q2 CY2026 Expectations, Stock Soars Online grocery delivery platform Instacart (NASDAQ:CART) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 14.1% year on year to $1.04 billion. Its GAAP profit of $0.45 per share was 16.6% below …

PIMCO discloses 1.89M-share Carter's Inc (CRI) position in Schedule 13G

PIMCO has reported a 5.1% beneficial ownership stake in Carter's Inc. (CRI), totaling 1,890,588 shares of common stock. This disclosure was made in a Schedule 13G filing, indicating PIMCO, as an investment adviser, holds sole voting and dispositive power over these shares for its …

Earnings Flash (CART) Maplebear Inc. dba Instacart Reports Q2 Revenue $1.04B, vs. FactSet Est of $1.03B

Maplebear Inc. (Instacart) reported Q2 revenue of $1.04 billion, surpassing FactSet estimates of $1.03 billion. The company also provided a stronger-than-expected outlook for Q3 revenue, projecting a range of $10.30 billion to $10.55 billion, and Q3 Adjusted EPS between $320.00 and $340.00, driven by …

Instacart Announces Second Quarter 2026 Financial Results

GTV grew 14% year-over-year and total revenue grew 14% year-over-year GAAP net income of $111 million; Adjusted EBITDA of $313 million, up 19% year-over-year SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Instacart (NASDAQ: CART) today released financial results for its second quarter ended June …

What Carter's (CRI)'s Strong Q2 Rebound And Completed Buybacks Means For Shareholders

Carter's, Inc. reported strong Q2 2026 results with sales of US$615.49 million and net income of US$104.96 million, alongside the completion of a US$97.57 million share repurchase program. Management projects approximately US$750 million in Q3 net sales and 2% to 3% full-year sales growth …

Cartesian Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Cartesian Therapeutics, Inc. announced its financial results for the second quarter and six months ended June 30, 2026. For the second quarter, the company reported a net income of $15.77 million. However, for the six-month period, the company posted a net loss of $23.41 …

Understanding The Descartes Systems Group’s (DSGX) Recent Stock Decline Despite Impressive Revenue

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

Cartesian Therapeutics Q2 2026 earnings: R&D spending rises as Phase 3 advances

Cartesian Therapeutics (NASDAQ: RNAC) reported Q2 2026 revenue of $0, with a diluted EPS of $0.46. The company experienced an increase in R&D spending due to the advancement of its Phase 3 AURORA trial, which widened its operating loss. However, a significant fair-value gain …

Cartesian Therapeutics Reports Q2 2026 Results, Advances Descartes-08 Clinical Trials and WestGene In Vivo Partnership

Cartesian Therapeutics announced significant progress in its clinical trials for Descartes-08, a cell therapy for autoimmune diseases, including the Phase 3 AURORA trial for myasthenia gravis and Phase 2 TRITON trial for myositis, with data expected in Q1 and H1 2027, respectively. The company …

Cartesian Therapeutics reports Q2 2026: $149.3M cash; net income $15.8M; Phase 3 MG data expected 1Q27

Cartesian Therapeutics reported its Q2 2026 financial results, including $149.3 million in cash and a net income of $15.8 million. The company announced that its Phase 3 AURORA trial for Descartes-08 in myasthenia gravis is on track, with data expected in Q1 2027 and …

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Cartesian Therapeutics reported its Q2 2026 financial results, highlighting significant progress in its clinical pipeline and an extended cash runway into 2028. Key advancements include the Phase 3 AURORA trial for myasthenia gravis, a new strategic partnership with WestGene for an in vivo CAR-T …

Cartesian Therapeutics (Nasdaq: RNAC) Q2 earnings boosted by CVR revaluation

Maplebear Inc. (NASDAQ:CART) Given Average Rating of "Moderate Buy" by Brokerages

Maplebear Inc. (NASDAQ:CART) has received an average "Moderate Buy" rating from 24 brokerages, with an average 12-month price target of $51.67, exceeding its opening price of $45.35. The company recently reported a 13.6% year-over-year revenue growth to $1.02 billion, slightly above estimates, though its …

CarTrade Tech FY26 Profit Jumps 68%, But Can Growth Justify Its Valuation?

Descartes Systems Group (NASDAQ:DSGX) Displays Strong Growth and a Bull Flag Technical Setup

Maplebear (CART) Earnings Date and Reports 2026 $CART

Maplebear (CART) After Earnings Optimism And Caper Cart Expansion Looks Undervalued

Maplebear (CART), known for its Instacart unit and AI-powered Caper smart trolleys, is gaining investor optimism following fresh earnings projections. Despite a recent 19.37% share price rebound over 90 days, the company is considered 11.6% undervalued with a fair value pegged at $51.30. Its …

Director Gregory Feldmann of Carter Bankshares (CARE) gifts 280 shares

Gregory W. Feldmann, a director at Carter Bankshares (CARE), made a bona fide gift transfer of 280 shares of common stock to university alumni on August 4, 2026. Following this transaction, Feldmann directly holds 16,921 shares of Carter Bankshares common stock. The gifted shares …

CarTrade Tech Q1 Results: EBITDA surges 45%, Revenue hits ₹230 crore

Should Value Investors Buy Carter's (CRI) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends …

Unveiling Maplebear (CART) Q2 Outlook: Wall Street Estimates for Key Metrics

The upcoming report from Maplebear (CART) is expected to reveal quarterly earnings of $0.55 per share, indicating an increase of 34.2% compared to the year-ago period. Analysts forecast revenues of $1.02 billion, representing an increase of 12.1% year over year. The consensus EPS estimate …

Earnings To Watch: Maplebear Inc (CART) Q2 2026 -- GF Value Sees 12% Upside

Maplebear Inc (CART) is scheduled to release its Q2 2026 earnings on August 6, 2026. Analysts project revenue of $1027.30 million and earnings of $0.54 per share for the quarter, with full-year 2026 estimates at $4201.27 million revenue and $2.42 earnings per share. The …

Enterprise value to revenue forward of Cartesian Therapeutics, Inc. – MUN:1S70

The article focuses on the enterprise value to revenue forward metric for Cartesian Therapeutics, Inc. (MUN:1S70), listed on the Munich Stock Exchange. It provides financial overview, documents, news, community insights, forecasts, seasonals, and ETF information related to the company. The content appears to be …

What's Maplebear's Probability of an Earnings Beat This Season?

With Maplebear Inc. CART, doing business as Instacart, set to report its second-quarter 2026 earnings results on Aug. 6, after the market closes, investors are asking an important question: Can the company return to its earnings-beat track after last quarter's slight miss, or will …

Descartes Introduces New AI-Powered Free Trade Intelligence (FTI) Solution to Help Reduce Trade Costs

Descartes Systems Group has launched its new AI-enabled Free Trade Intelligence (FTI) solution designed to help manufacturers, importers, and exporters reduce trade costs by optimizing sourcing and trade decisions. This solution leverages AI to analyze various trade data, enabling faster qualification for preferential tariff …

Descartes Systems Group Launches AI-Powered Solution to Reduce Trade Costs

Descartes Systems Group has introduced a new AI-powered free trade intelligence solution aimed at reducing trade costs for businesses. This offering leverages artificial intelligence to help companies manage and optimize their international trade processes, including customs compliance and global trade research. The solution is …

Descartes AI Tool Analyzes Rules of Origin Across More Than 250 Regimes

Descartes Systems Group (DSGX) has launched an AI-powered Free Trade Intelligence (FTI) solution designed to help manufacturers, importers, and exporters reduce costs by optimizing free trade agreement usage. The FTI solution analyzes bills of materials, tariff classifications, and rules of origin across more than …

Descartes Schedules a 5:30 p.m. ET Results Call Sept. 10

Descartes Systems Group (Nasdaq: DSGX) will release its second quarter fiscal 2027 financial results after market close on Thursday, September 10, 2026. The company's executive management will host a conference call at 5:30 p.m. ET on the same day to discuss the results. Replays …

Descartes Sets Date to Announce Second Quarter Fiscal 2027 Financial Results

WATERLOO, Ontario and ATLANTA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its second quarter fiscal 2027 financial results after market close on Thursday, September 10, …

Carter’s Inc. Names Tinuiti Full-Funnel Agency of Record to Drive Brand and Performance Growth

Carter’s Inc. has appointed Tinuiti as its Full-Funnel Agency of Record for all its brands in the U.S. and Canada. Tinuiti will leverage its proprietary Bliss Point technology to unify Carter's brand and performance investments, providing clarity across its media portfolio and connecting investments …